期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
静脉溶栓及肝素治疗对AMI患者血浆纤维蛋白肽A昼夜节律的影响 被引量:1
1
作者 宋杰 于全俊 +3 位作者 高润霖 赵秀文 杨跃进 陈纪林 《临床荟萃》 CAS 1999年第5期212-213,共2页
静脉溶栓治疗挽救了大量急性心肌梗塞(AMI)患者的生命,但各种溶栓治疗方案所面临的出血和冠脉开通后再闭塞,是溶栓治疗的另一急需解决的重大临床问题。其中凝血、血小板功能的变化起主要作用,对溶栓治疗后凝血、血小板功能变化的研究仍... 静脉溶栓治疗挽救了大量急性心肌梗塞(AMI)患者的生命,但各种溶栓治疗方案所面临的出血和冠脉开通后再闭塞,是溶栓治疗的另一急需解决的重大临床问题。其中凝血、血小板功能的变化起主要作用,对溶栓治疗后凝血、血小板功能变化的研究仍有重要临床参考价值。为此,本研究探讨了静脉溶栓及肝素治疗是否影响AMI患者血浆纤维蛋白肽A(FibrinopeptideA,简称FPA)的昼夜节律及停用静脉肝素改为皮下注射后FPA昼夜节律的变化。 1 病例与方法 1.1病例 选择1997年1月至5月我院冠心病监护病房发病在6小时内的12例AMI患者。9例采用尿激酶(UK),3例采用重组织型纤溶酶原激活物(rt-PA)进行静脉溶栓治疗。溶栓开始即刻静脉注射肝素钙5000U,90分钟后静脉输注1000U/小时,监测aPTT在60~85秒之间,第3天改为10000U皮下注射2次/日。同时给予阿斯匹林300mg/d口服,7天后改为50mg/d。同时选择冠状动脉造影阳性的非AMI的冠心病患者9例,仅服用阿斯匹林50mg/d而未用其他抗凝药物者作为对照组。 展开更多
关键词 心肌梗塞 AMI 药物疗法 静脉溶栓 肝素 FPA
在线阅读 下载PDF
RE-EVALUATION OF THE MECHANISM AND TREATMENT OF ANGINA DECUBITUS 被引量:1
2
作者 陈纪林 陈在嘉 +5 位作者 徐义枢 高润霖 寇文蓉 姚康宝 于全俊 陶寿琪 《Chinese Medical Sciences Journal》 CAS CSCD 1996年第1期8-12,共5页
patients with angina decubitus (AD) were studied during hospitalization. These patients were found to have severe coronary artery obstructive lesions and an increase of myocardial oxygen consumption (MOC) before the o... patients with angina decubitus (AD) were studied during hospitalization. These patients were found to have severe coronary artery obstructive lesions and an increase of myocardial oxygen consumption (MOC) before the onset to AD, indicating that AD belongs to the category of effort angina.18 patients were investigated by continuous hemodynamic monitoring. Three patients had significant increase in pulmonary artery diastolic pressure (PADP) before the onset. In the other 15 patients. PADP increased slightly in 12 and remained unchanged in 3 cases before the onset. Left ventriculography showed ejection fraction (EF)>45% in 25 of the 27 patients. These results indicate that left ventricular (LV) systolic dysfunction is not a major factor in the Pathogenesis of AD. The patients with LVEDP>12 mmHg constituted 60% of 25 patients with EF>45%, suggesting that these patients had ohvious LV diastolic dysfunction, which may be the major factor in the pathogenesis of AD.According to the results of our treatment, beta blockers may be used as the major form of tteatment in the patients with AD. 展开更多
关键词 angina decubitus LV diastolic dysfunction beta blockers
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部